Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial

Author： Akhondzadeh S. Tavakolian R. Davari-Ashtiani R. Arabgol F. Amini H.

Publisher： Elsevier

ISSN： 0278-5846

Source： Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol.27, Iss.5, 2003-08, pp. : 841-845

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Randomized, Double-Blind, Crossover Study of Once-Daily Dexmethylphenidate in Children with Attention-Deficit Hyperactivity Disorder: Rapid Onset of Effect

By Brams Matthew

CNS Drugs, Vol. 22, Iss. 8, 2008-01 ,pp. : 693-704

Adis International

Access to resources Recommend Favorite

Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6-12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial

By Connor Daniel F.

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 755-768

Adis International

Access to resources Recommend Favorite

Double-blind, placebo-controlled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder

By Bilici M. Yildirim F. Kandil S. Bekaroglu M. Yildirmis S. Deger O. Ulgen M. Yildiran A. Aksu H.

Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 28, Iss. 1, 2004-01 ,pp. : 181-190

Elsevier

Access to resources Recommend Favorite

Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: Safety Considerations

By Wolraich Mark L. McGuinn Laura Doffing Melissa

Drug Safety, Vol. 30, Iss. 1, 2007-01 ,pp. : 17-26

Adis International

Access to resources Recommend Favorite

Lisdexamfetamine is a promising treatment for children with attention-deficit hyperactivity disorder

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite